Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Institut Für Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest

Clinical trials sponsored by Institut Für Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest, explained in plain language.

Trials to join now! 1

New combo therapy shows promise for Hard-to-Treat colorectal cancer

Disease control Recruiting now

This study tests whether combining two drugs, fruquintinib and tislelizumab, can help people with a specific type of advanced colorectal cancer that has not spread to the liver. The trial includes 140 adults whose cancer is stable (MSS/pMMR) and cannot be removed by surgery. The …

Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated Apr 23, 2026 12:44 UTC